|
|
Changes of human leukocyte antigen-B27 and inflammatory indexs in patients with spondyloarthritis and its clinical significance |
ZHANG Jia-yong GUO Jin SHEN Jie CHEN Yu-ling |
Department of Rheumatology and Immunology,Mindong Hospital Affiliated to Fujian Medical University,Fujian Province,Fu′an 355000,China |
|
|
Abstract Objective To investigate the changes of human leukocyte antigen-B27 and inflammatory indexs in patients with spondyloarthritis (SpA) and its clinical significance.Methods A total of 196 cases of SpA patients admitted to our hospital from January 2014 to December 2018,which met the research conditions,were selected as the SpA group,and 200 cases of healthy physical examination patients who were examined in our hospital during the same period were selected as the healthy control group.Blood HLA-B27,tumor necrosis factor-α (TNF-α),C-reactive protein (CRP),urinary color doppler ultrasound and abdominal orthotopic X-ray were detected.The occurrence of urolithiasis in the two groups was observed and compared.HLA-B27 positive rate,TNF-α and CRP levels of patients with urolithiasis (+)SpA group and patients with urolithiasis (-) SpA group were compared.Results The incidence of urolithiasis in SpA group was 19.89% (35/176),which was higher than 3.00% (6/200) in healthy control group,the difference was statistically significant (P<0.01).The HLA-B27 positive rate in urolithiasis (+) SpA group (82.86%) was higher than that in urolithiasis (-) SpA group (60.99%),the difference was statistically significant (P<0.05).The levels of TNF-α and CRP in urolithiasis (+) SpA group were higher than those in urolithiasis (-) SpA group,the differences were statistically significant (P<0.05).Conclusion The incidence of urolithiasis in patients with SpA is high,the HLA-B27,TNF-α,and CRP have a certain predictive effect on the risk of urolithiasis.
|
|
|
|
|
[1] |
Zeng QY,Chen R,Darmawan J,et al.Rheumatic diseases in China[J].Arthritis Res Ther,2008,10(1):1-11.
|
[2] |
Sari I,Haroon N.Disease modification in axial spondyloarthritis[J].Best Pract Res Clin Rheumatol,2018,32(3):427-439.
|
[3] |
Tong F,Lv Q,Li A,et al.An epidemiological study of the prevalence rate of inflammatory back pain and axial spondyloarthritis in a university in the south of China[J].Clin Rheumatol,2018,37(11):3087-3091.
|
[4] |
Jhaj G,Kopplin LJ.Ocular features of the HLA-B27-positive seronegative spondyloarthropathies[J].Curr Opin Ophthalmol,2018,29(6):552-557.
|
[5] |
Syrbe U,Baraliakos X.Spondyloarthritis[J].Z Rheumatol,2018,77(9):783-788.
|
[6] |
Gill T,Asquith M,Brooks SR,et al.Effects of HLA-B27 on gut microbiota in experimental spondyloarthritis implicate an ecological model of dysbiosis[J].Arthritis Rheumatol,2018,70(4):555-565.
|
[7] |
Rosenbaum JT,Davey MP.Time for a gut check:evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome [J].Arthritis Rheum,2011,63(11):3195-3198.
|
[8] |
Korkmaz C,Cansu DU,Sayer JA.Urolithiasis as an extraarticular manifestation of ankylosing spondylitis[J].Rheumatol Int,2017,37(12):1949-1956.
|
[9] |
Gonüllü E,Bilge NSY,Cansu DU,et al.Risk factors for urolithiasis in patients with ankylosing spondylitis:a prospective case-control study[J].Urolithiasis,2017,45(4):353-357.
|
[10] |
Lui NL,Carty A,Haroon N,et al.Clinical correlates of urolithiasis in ankylosing spondylitis[J].J Rheumatol,2011,38(9):1953-1956.
|
[13] |
谭立明,冯晓晶,焦安君,等.强直性脊柱炎患者检测骨代谢指标潜在的临床价值[J].中国免疫学杂志,2017,33(10):1543-1546.
|
[11] |
Incel NA,Gokoglu F,Nacir B,et al.Bone and stone in ankylosing spondylitis:osteoporosis and urolithiasis[J].Clin Rhe umatol,2006,25(5):667-670.
|
[12] |
Fallahi S,Jamshidi AR,Gharibdoost F,et al.Urolithiasis in ankylosing spondylitis:Correlation with Bath ankylosing spondylitis disease activity index(BASDAI),Bath ankylosing spondylitis functional index(BASFI)and Bath ankylosing spondylitis metrology index(BASMI)[J].Caspian J Intern Med,2012,3(4):508-513.
|
[14] |
Liu KG,He QH,Tan JW,et al.Expression of TNF -α,VEGF,and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis[J].Genet Mol Res,2015,14(2):6852-6858.
|
[15] |
Jones A,Ciurtin C,Ismajli M,et al.Biologics for treating axial spondyloarthritis[J].Expert Opin Biol Ther,2018,18(6):641-652.
|
|
|
|